One-Carbon Insertion and Polarity Inversion Enabled a Pyrrole Strategy to the Total Syntheses of Pyridine-Containing Lycopodium Alkaloids: Complanadine A and Lycodine
- PMID: 34570487
- PMCID: PMC9123642
- DOI: 10.1021/jacs.1c08626
One-Carbon Insertion and Polarity Inversion Enabled a Pyrrole Strategy to the Total Syntheses of Pyridine-Containing Lycopodium Alkaloids: Complanadine A and Lycodine
Abstract
Complanadine A and lycodine are representative members of the Lycopodium alkaloids with a characteristic pyridine-containing tetracyclic skeleton. Complanadine A has demonstrated promising neurotrophic activity and potential for persistent pain management. Herein we report a pyrrole strategy enabled by one-carbon insertion and polarity inversion for concise total syntheses of complanadine A and lycodine. The use of a pyrrole as the pyridine precursor allowed the rapid construction of their tetracyclic skeleton via a one-pot Staudinger reduction, amine-ketone condensation, and Mannich-type cyclization. The pyrrole group was then converted to the desired pyridine by the Ciamician-Dennstedt rearrangement via a one-carbon insertion process, which also simultaneously introduced a chloride at C3 for the next C-H arylation. Other key steps include a direct anti-Markovnikov hydroazidation, a Mukaiyama-Michael addition, and a Paal-Knorr pyrrole synthesis. Lycodine and complanadine A were prepared in 8 and 11 steps, respectively, from a readily available known compound.
Figures
References
-
- Mintun MA; Lo AC; Evans CD; Wessels AM; Ardayfio PA; Andersen SW; Shcherbinin S; Sparks J; Sims JR; Brys M; Apostolova LG; Salloway SP; Skovronsky DM Donanemab in Early Alzheimer’s Disease. N. Engl. J. Med 2021, 384, 1691–1704. - PubMed
- FDA’s Decision to Approve New Treatment for Alzheimer’s Disease:https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-... (accessed 2021-08-16).
- Mullard A Landmark Alzheimer’s drug approval confounds research community. Nature 2021, 594, 309–310. - PubMed
-
- Sofroniew MV; Howe CL; Mobley WC Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci 2001, 24, 1217–1281. - PubMed
-
- Wilson RW; Danishefsky SJ Applications of Total Synthesis to Problems in Neurodegeneration: Fascinating Chemistry along the Way. Acc. Chem. Res 2006, 39, 539–549. - PubMed
- Xu J; Lacoske MH; Theodorakis EA Neurotrophic Natural Products: Chemistry and Biology. Angew. Chem. Int. Ed 2014, 53, 956–987. - PMC - PubMed
- Shenvi RA Neurite Outgrowth Enhancement by Jiadifenolide: Possible Targets. Nat. Prod. Rep 2016, 33, 535–539. - PubMed
-
- Ma X; Gang DR The Lycopodium alkaloids. Nat. Prod. Rep 2004, 21, 752–772. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
